Global Cannabis Industry Round-Up
June 2026 Edition
Global Cannabis Industry Round-Up
July reinforced a growing reality across the global cannabis industry:
The opportunities are getting bigger — but so are the risks.
Canadian producers are expanding their influence in international medical markets. Germany and the UK continue creating new demand. U.S. regulators are testing new business models and reconsidering long-standing legal barriers.
But expansion is also introducing greater complexity.
International deals require stronger due diligence. Federal reform continues colliding with state-level resistance. Mature markets are searching for new ways to support struggling operators. And companies under financial pressure are still navigating legal systems that were never designed for federally prohibited businesses.
The industry is moving forward.
But the next phase will reward companies that understand not only where the opportunities are, but what it takes to pursue them responsibly.
Canada
International Opportunity Continues to Grow
Canada remains one of the world's most established legal cannabis markets, but July highlighted how the country's future growth is increasingly tied to international demand.
While consumer preferences continue shifting toward extracts, edibles, and value-added products at home, Canadian producers are strengthening their position as trusted suppliers to medical markets abroad.
At the same time, companies exploring international expansion are being reminded that global opportunities require more than ambition—they require diligence.
Across the country, businesses continue focusing on:
International export opportunities
Product innovation
Operational efficiency
Brand differentiation
Strategic partnerships
Provincial Updates
Ontario – Ontario continues refining its wholesale and retail ecosystem while maintaining Canada's largest legal cannabis market. Competition remains intense, with producers and retailers focused on innovation and operational efficiency.
Alberta – Alberta's highly competitive retail market continues expanding, although municipalities remain carefully balancing new store approvals with local planning requirements.
British Columbia – British Columbia continues supporting Indigenous participation in the legal cannabis industry while craft producers remain focused on premium products and differentiated consumer experiences.
Québec – Québec's government-controlled model continues delivering stable performance, while provincial research suggests cannabis consumption has largely stabilized following legalization.
Product Trends – New market data shows extracts and edibles continue gaining market share, highlighting changing consumer preferences beyond traditional dried flower.
International Exports – Canadian producers now supply the majority of the United Kingdom's medical cannabis market, while Germany continues creating significant export opportunities for licensed producers across the country.
International Trade – Industry leaders are encouraging greater due diligence when pursuing international cannabis deals, emphasizing the importance of verifying partners, licences, financing, and regulatory compliance before entering new markets.
United States
Innovation Continues Despite Regulatory Complexity
The U.S. cannabis market remains one of the industry's most dynamic—and most complicated.
While federal reform remains uncertain, individual states continue introducing new business models, legal interpretations, and regulatory approaches that are reshaping the market.
State Updates
California – San Francisco approved Amsterdam-style cannabis cafés, allowing licensed businesses to serve food and beverages alongside on-site cannabis consumption. The move is designed to create new revenue opportunities for retailers while offering consumers a more social cannabis experience.
Wyoming – Wyoming announced it would not recognize federal cannabis rescheduling, highlighting the continued divide between federal policy and state implementation.
Ohio – Regulators continue refining the state's adult-use cannabis framework following the successful launch of legal sales earlier this year. As the market matures, attention is shifting toward licensing, supply, and long-term market stability.
Minnesota – Minnesota continues building its adult-use cannabis program, with licensing and regulatory development progressing ahead of a broader retail rollout. The state remains one of the industry's newest growth markets.
New York – Enforcement efforts against illicit operators continued throughout July as the state works to strengthen its legal retail market and create a more level playing field for licensed businesses.
Federal Courts – A landmark cross-border bankruptcy ruling involving The Cannabist Company may provide a new restructuring pathway for certain cannabis businesses operating internationally.
Federal Reform Watch – Cannabis rescheduling remains under review, with operators continuing to monitor how future federal decisions could affect taxation, banking, investment, and interstate commerce.
Europe
Medical Markets Continue Building Momentum
Europe's cannabis industry continues shifting from emerging opportunity to established medical market.
July demonstrated that patient demand remains strong, but long-term success is increasingly being driven by supply chain reliability, product quality, and international partnerships.
Country Updates
Germany – Germany's medical cannabis market continues maturing, with suppliers increasingly competing on product quality, pricing, and reliable inventory as patient demand continues to grow.
United Kingdom – The UK remains one of Europe's fastest-growing medical cannabis markets, with Canadian producers now supplying the majority of imports and patient access continuing to expand.
France – France moved closer to launching a permanent medical cannabis framework, signalling continued momentum toward broader patient access following its national pilot program.
Portugal – Portugal continues reinforcing its role as one of Europe's leading cultivation and export hubs, although industry participants are calling for greater regulatory clarity to support future growth.
Europe-Wide Development – As cross-border trade accelerates, the conversation is shifting from legalization to execution. Supply chain resilience, regulatory compliance, and trusted international partnerships are becoming the defining factors for long-term success across Europe's medical cannabis industry.
Talent Implications
Global Experience Becomes a Competitive Advantage
As cannabis businesses expand across borders, hiring priorities continue evolving.
Companies are increasingly seeking professionals who can navigate international regulations, build strategic partnerships, and manage increasingly complex operations.
We're continuing to see demand for:
International business development professionals
Regulatory and compliance specialists
Supply chain and logistics leaders
Finance and restructuring executives
Commercial leaders with export experience
Operations professionals with global market expertise
At the same time, employers continue placing greater emphasis on:
Cross-border experience
Risk management
Commercial due diligence
Strategic thinking
Proven operational execution
Closing Thought
July reinforced another important shift in the cannabis industry:
Growth is no longer defined by simply entering new markets.
It's defined by how well companies operate within them.
Across Canada, the United States, and Europe, businesses are becoming more sophisticated, international partnerships are becoming more important, and execution is increasingly separating market leaders from everyone else.
The companies gaining momentum today aren't simply expanding.
They're:
Building trusted international relationships
Investing in operational excellence
Managing risk alongside opportunity
Hiring leaders who understand increasingly complex markets
The next chapter of the cannabis industry won't be defined by who grows the fastest.
It will be defined by who grows the smartest.
